{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T19:27:36Z","timestamp":1784921256130,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jcf.2018.05.005","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T02:08:07Z","timestamp":1528337287000},"page":"798-803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Continuous glucose monitoring guided insulin therapy is associated with improved clinical outcomes in cystic fibrosis-related diabetes"],"prefix":"10.1016","volume":"17","author":[{"given":"Freddy","family":"Frost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Dyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip","family":"Nazareth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Walshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jcf.2018.05.005_bb0005","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"issue":"Suppl. 44","key":"10.1016\/j.jcf.2018.05.005_bb0010","first-page":"26","article-title":"Understanding cystic-fibrosis-related diabetes: best thought of as insulin deficiency?","volume":"97","author":"Dobson","year":"2004","journal-title":"J R Soc Med"},{"issue":"8","key":"10.1016\/j.jcf.2018.05.005_bb0015","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ppul.21495","article-title":"Cystic fibrosis related diabetes (CFRD)\u2014the end stage of progressive insulin deficiency","volume":"46","author":"Hameed","year":"2011","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.jcf.2018.05.005_bb0020","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jcf.2011.11.001","article-title":"Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus","volume":"11","author":"Hillman","year":"2012","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2018.05.005_bb0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0168-8227(99)00058-3","article-title":"Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report","volume":"45","author":"Moran","year":"1999","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1016\/j.jcf.2018.05.005_bb0030","doi-asserted-by":"crossref","first-page":"E200","DOI":"10.1152\/ajpendo.00333.2015","article-title":"CFTR silencing in pancreatic beta-cells reveals a functional impact on glucose-stimulated insulin secretion and oxidative stress response","volume":"310","author":"Ntimbane","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jcf.2018.05.005_bb0035","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ppul.1142","article-title":"Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European epidemiologic registry of cystic fibrosis","volume":"32","author":"Koch","year":"2001","journal-title":"Pediatr Pulmonol"},{"issue":"9","key":"10.1016\/j.jcf.2018.05.005_bb0040","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/BF01957574","article-title":"Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis","volume":"151","author":"Lanng","year":"1992","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jcf.2018.05.005_bb0045","series-title":"Management of cystic fibrosis related diabetes mellitus","author":"Littlewood","year":"2004"},{"issue":"4","key":"10.1016\/j.jcf.2018.05.005_bb0050","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1378\/chest.12-1934","article-title":"Evidence of vascular endothelial dysfunction in young patients with cystic fibrosis","volume":"143","author":"Poore","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2018.05.005_bb0055","series-title":"Cystic fibrosis related diabetes: Section 1.7.23","article-title":"Cystic fibrosis: Diagnosis and management (NICE guidance NG78)","author":"NICE","year":"2017"},{"issue":"6","key":"10.1016\/j.jcf.2018.05.005_bb0060","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.2337\/diacare.26.6.1940-a","article-title":"Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis","volume":"26","author":"Dobson","year":"2003","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.jcf.2018.05.005_bb0065","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/dc08-1925","article-title":"Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study","volume":"32","author":"O'Riordan","year":"2009","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jcf.2018.05.005_bb0070","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jpeds.2005.05.004","article-title":"Continuous glucose monitoring in adolescents with cystic fibrosis","volume":"147","author":"Jefferies","year":"2005","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.jcf.2018.05.005_bb0075","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jcf.2018.05.005_bb0080","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/dc09-1492","article-title":"Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain","volume":"33","author":"Hameed","year":"2010","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jcf.2018.05.005_bb0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000110206","article-title":"Long-term effect of insulin treatment in cystic fibrosis-related diabetes","volume":"76","author":"Mohan","year":"2008","journal-title":"Respiration"},{"issue":"7","key":"10.1016\/j.jcf.2018.05.005_bb0090","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ppul.20831","article-title":"Management of cystic fibrosis related diabetes: a survey of UK cystic fibrosis centers","volume":"43","author":"Mohan","year":"2008","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.jcf.2018.05.005_bb0095","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jcf.2013.11.005","article-title":"Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients","volume":"13","author":"Leclercq","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2018.05.005_bb0100","doi-asserted-by":"crossref","first-page":"1527932","DOI":"10.1155\/2016\/1527932","article-title":"Glucose >200 mg\/dL during continuous glucose monitoring identifies adult patients at risk for development of cystic fibrosis related diabetes","volume":"2016","author":"Taylor-Cousar","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jcf.2018.05.005_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2018.03.008","article-title":"Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline","author":"Chan","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2018.05.005_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2017.12.004","article-title":"Quantifying fluctuation in glucose levels to identify early changes in glucose homeostasis in cystic fibrosis","author":"Brugha","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2018.05.005_bb0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcf.2006.03.009","article-title":"Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis","volume":"6","author":"Brennan","year":"2007","journal-title":"J Cyst Fibros"},{"issue":"9","key":"10.1016\/j.jcf.2018.05.005_bb0120","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/thx.2004.035766","article-title":"Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patients","volume":"60","author":"Philips","year":"2005","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.jcf.2018.05.005_bb0125","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1464-5491.2004.01219.x","article-title":"Conventional measures underestimate glycaemia in cystic fibrosis patients","volume":"21","author":"Dobson","year":"2004","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.jcf.2018.05.005_bb0130","doi-asserted-by":"crossref","first-page":"RC1","DOI":"10.1007\/BF03345538","article-title":"Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance","volume":"29","author":"Bizzarri","year":"2006","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.jcf.2018.05.005_bb0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4239\/wjd.v5.i2.89","article-title":"New insights into insulin: the anti-inflammatory effect and its clinical relevance","volume":"5","author":"Sun","year":"2014","journal-title":"World J Diabetes"},{"issue":"3","key":"10.1016\/j.jcf.2018.05.005_bb0140","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jcf.2008.12.002","article-title":"Nutritional decline in cystic fibrosis related diabetes: the effect of intensive nutritional intervention","volume":"8","author":"White","year":"2009","journal-title":"J Cyst Fibros"},{"issue":"10","key":"10.1016\/j.jcf.2018.05.005_bb0145","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1210\/en.2017-00187","article-title":"CFTR influences Beta cell function and insulin secretion through non-cell autonomous exocrine-derived factors","volume":"158","author":"Sun","year":"2017","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.jcf.2018.05.005_bb0150","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1172\/JCI60610","article-title":"Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets","volume":"122","author":"Olivier","year":"2012","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.jcf.2018.05.005_bb0155","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2337\/dc10-1279","article-title":"Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.jcf.2018.05.005_bb0160","doi-asserted-by":"crossref","first-page":"H1479","DOI":"10.1152\/ajpheart.00136.2016","article-title":"Evidence of microvascular dysfunction in patients with cystic fibrosis","volume":"310","author":"Rodriguez-Miguelez","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"10.1016\/j.jcf.2018.05.005_bb0165","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/adc.2010.204636","article-title":"Once daily insulin detemir in cystic fibrosis with insulin deficiency","volume":"97","author":"Hameed","year":"2012","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.jcf.2018.05.005_bb0170","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/adc.87.5.430","article-title":"Clinical improvement in cystic fibrosis with early insulin treatment","volume":"87","author":"Dobson","year":"2002","journal-title":"Arch Dis Child"},{"issue":"10","key":"10.1016\/j.jcf.2018.05.005_bb0175","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc09-0585","article-title":"Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jcf.2018.05.005_bb0180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.endinu.2017.08.008","article-title":"Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients","volume":"65","author":"Clemente Leon","year":"2018","journal-title":"Endocrinol Diabetes Nutr"},{"issue":"6","key":"10.1016\/j.jcf.2018.05.005_bb0185","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/archdischild-2017-314250","article-title":"Continuous glucose monitoring to evaluate glycaemic abnormalities in cystic fibrosis","volume":"103","author":"Zorron Mei Hsia Pu, M., et al.","year":"2018","journal-title":"Arch Dis Child"},{"issue":"7","key":"10.1016\/j.jcf.2018.05.005_bb0190","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1055\/s-2008-1062723","article-title":"Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance","volume":"40","author":"Moreau","year":"2008","journal-title":"Horm Metab Res"},{"issue":"2","key":"10.1016\/j.jcf.2018.05.005_bb0195","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jcf.2015.03.013","article-title":"HbA1c as a screening tool for cystic fibrosis related diabetes","volume":"15","author":"Burgess","year":"2016","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199318305873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199318305873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:39:19Z","timestamp":1761601159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199318305873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1569199318305873"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2018.05.005","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous glucose monitoring guided insulin therapy is associated with improved clinical outcomes in cystic fibrosis-related diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2018.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}